French researchers have developed a noninvasive ultrasound therapy to treat certain patients with aortic stenosis. In a small study published in The Lancet, they demonstrated its effectiveness.

Valvosoft has been authorised to treat patients with severe symptomatic aortic stenosis (sSAS) who may be ineligible for other treatments such as transcatheter aortic valve replacement (TAVR). Image ...

Butterfly Network Inc. (NYSE:BFLY) is one of the most promising penny stocks under $5. On August 5, Butterfly Network announced advancements in AI-powered screening for aortic valve and aorta ...

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today ...

Delivering short pulses of high-pressure ultrasound to calcified bioprostheses may soften the valves and relieve stenosis, new preclinical and in vitro data show. The hope is that one day, with ...

PARIS--(BUSINESS WIRE)--Cardiawave SA, a deeptech medical device company that has developed VALVOSOFT® a revolutionary non-invasive medical device to treat aortic stenosis, the most prevalent heart ...

ELKHART, Ind. (WSBT) — Al Cover is walking and exercising again the way he was a few years ago. “I'm back to where I was before, doing hills. And in my work, my partners recognize the increase in my ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared a point-of-care AI ultrasound tool for the diagnosis of multiple cardiac pathologies. The ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Aortic stenosis, a narrowing of the aortic valve, affects over 13% of Americans over 75 years old and is often missed until it’s advanced and symptomatic. Studies(1, 2) suggest that a significant ...